疤痕治疗市场－全球产业规模、份额、趋势、机会和预测，按产品、疤痕产品、最终用户、地区和竞争细分，2020-2030 年

2024 年全球疤痕治疗市场价值为 28.7 亿美元，预计到 2030 年将达到 54.8 亿美元，预测期内复合年增长率为 11.38%。市场成长主要得益于人们对美观的认识不断提高、道路和烧伤案件的增加以及引入先进治疗设备的技术创新。 COVID-19 疫情进一步影响了市场，加速了远距医疗在初次咨询和后续护理中的应用，使疤痕治疗变得更容易，而无需频繁去医院。根据美国整形外科医师协会的数据，2022 年美国进行了约 50,930 例疤痕修復手术，凸显了整容手术的上升趋势。对美观的追求导致人们越来越多地采用手术和非手术疤痕治疗方案。

关键市场驱动因素

道路交通事故和烧伤发生率上升

主要市场挑战

高级疤痕治疗费用高昂

主要市场趋势

疤痕治疗技术的进步

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：顾客之声

第五章：全球疤痕治疗市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 依产品（外用产品、雷射产品、注射剂、其他）
  • 依疤痕产品分类（萎缩性疤痕、肥厚性疤痕和瘢瘤、挛缩性疤痕、妊娠纹）
  • 按最终使用者（医院和诊所、门诊护理中心、其他）
  • 按地区
  • 按公司分类（2024）
• 产品图
  • 按产品
  • 按疤痕类型
  • 按最终用户
  • 按地区

第六章：北美疤痕治疗市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲疤痕治疗市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 法国
  • 德国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太疤痕治疗市场展望

• 市场规模和预测
• 市场占有率和预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：南美疤痕治疗市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第十章：中东与非洲疤痕治疗市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：市场动态

• 驱动程式
• 挑战

第 12 章：市场趋势与发展

• 近期发展
• 併购
• 产品发布

第 13 章：全球疤痕治疗市场：SWOT 分析

第 14 章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 顾客的力量
• 替代产品的威胁

第 15 章：竞争格局

• Smith & Nephew PLC
• Lumenis Ltd.
• Merz Pharmaceuticals, LLC
• Sonoma Pharmaceuticals, Inc.
• Cynosure, LLC
• CCA Industries, Inc.
• Newmedical Technology Inc.
• Molnlycke Health Care AB
• Perrigo Company plc
• Enaltus LLC

第 16 章：策略建议

第17章调查会社について・免责事项

The Global Scar Treatment Market was valued at USD 2.87 billion in 2024 and is projected to reach USD 5.48 billion by 2030, registering a CAGR of 11.38% during the forecast period. Market growth is primarily driven by increasing awareness around aesthetic appearance, rising cases of road and burn injuries, and technological innovations introducing advanced treatment devices. The COVID-19 pandemic further influenced the market by accelerating the use of telemedicine for initial consultations and follow-up care, making scar treatment more accessible without the need for frequent hospital visits. According to the American Society of Plastic Surgeons, approximately 50,930 scar revision surgeries were conducted in the U.S. in 2022, highlighting a rising trend in cosmetic procedures. The pursuit of aesthetic improvement is leading to increased adoption of both surgical and non-surgical scar treatment solutions.

Key Market Drivers

Rising Incidence of Road Accidents and Burn Injuries

The global scar treatment market is being largely influenced by the surge in road accidents and burn injuries. Data from the Population Reference Bureau indicates that about 50 million individuals suffer road accident injuries annually, many of whom require scar treatment. In the U.S., the CDC notes around 1.1 million burn injuries each year that require medical care, with roughly 50,000 cases necessitating hospitalization. These conditions frequently result in hypertrophic and keloid scars, causing both physical and emotional distress. This drives up demand for treatment options such as laser therapies, topical products, and surgeries. Additionally, government-backed reimbursement policies in countries like the U.S. further support access to these treatments, encouraging advancements and investment in the scar treatment industry.

Key Market Challenges

High Cost of Advanced Scar Treatment Procedures

A key obstacle in the scar treatment market is the considerable cost of advanced therapies, including laser treatments and surgical options. These high expenses can be prohibitive, especially in developing nations, where access to such services is limited. The situation is worsened by the general lack of insurance coverage for aesthetic treatments, forcing patients to pay out-of-pocket. This economic constraint limits market expansion and highlights the need for cost-effective treatment alternatives. Addressing this issue calls for coordinated action among stakeholders to explore affordable innovations and insurance solutions that make scar treatment more accessible.

Key Market Trends

Technological Advancements in Scar Treatment Modalities

Technological innovation is significantly enhancing scar treatment outcomes, improving both effectiveness and patient safety. Cutting-edge laser technologies such as Q-switched and fractional CO2 lasers are transforming the treatment of various scars. A notable advancement includes Cynosure's PicoSure Pro Device, launched in June 2022, aimed at treating acne scars, wrinkles, and pores. Simultaneously, the integration of telemedicine is reshaping how care is delivered. The rise of remote consultations and follow-ups-accelerated by the COVID-19 pandemic-has made scar treatment more convenient and accessible, especially for individuals in underserved or remote locations.

Key Market Players

• Smith & Nephew PLC
• Lumenis Ltd.
• Merz Pharmaceuticals, LLC
• Sonoma Pharmaceuticals, Inc.
• Cynosure, LLC
• CCA Industries, Inc.
• Newmedical Technology Inc.
• Molnlycke Health Care AB
• Perrigo Company plc
• Enaltus LLC

Report Scope:

In this report, the global scar treatment market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Scar Treatment Market, By Product:

• Topical Products
• Laser Products
• Injectables
• Others

Scar Treatment Market, By Scar Product:

• Atrophic Scars
• Hypertrophic & Keloid Scars
• Contracture Scars
• Stretch Marks

Scar Treatment Market, By End User:

• Hospitals & Clinics
• Ambulatory Care Centers
• Others

Scar Treatment Market, By Region:

• North America
  • United States
  • Mexico
  • Canada
• Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain
• Asia-Pacific
  • China
  • India
  • South Korea
  • Japan
  • Australia
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Scar Treatment Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validations
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Scar Treatment Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Topical Products, Laser Products, Injectables, Others)
  • 5.2.2. By Scar Product (Atrophic Scars, Hypertrophic & Keloid Scars, Contracture Scars, Stretch Marks)
  • 5.2.3. By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Product Map
  • 5.3.1. By Product
  • 5.3.2. By Scar Type
  • 5.3.3. By End User
  • 5.3.4. By Region

6. North America Scar Treatment Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Scar Type
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Scar Treatment Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Scar Type
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Scar Treatment Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Scar Type
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Scar Treatment Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Scar Type
      • 6.3.3.2.3. By End User

7. Europe Scar Treatment Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Scar Type
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Scar Treatment Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Scar Type
      • 7.3.1.2.3. By End User
  • 7.3.2. Germany Scar Treatment Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Scar Type
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Scar Treatment Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Scar Type
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Scar Treatment Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Scar Type
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Scar Treatment Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Scar Type
      • 7.3.5.2.3. By End User

8. Asia-Pacific Scar Treatment Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Scar Type
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Scar Treatment Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Scar Type
      • 8.3.1.2.3. By End User
  • 8.3.2. India Scar Treatment Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Scar Type
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Scar Treatment Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Scar Type
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Scar Treatment Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Scar Type
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Scar Treatment Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Scar Type
      • 8.3.5.2.3. By End User

9. South America Scar Treatment Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Scar Type
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Scar Treatment Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Scar Type
      • 9.3.1.2.3. By End User
  • 9.3.2. Argentina Scar Treatment Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Scar Type
      • 9.3.2.2.3. By End User
  • 9.3.3. Colombia Scar Treatment Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Scar Type
      • 9.3.3.2.3. By End User

10. Middle East and Africa Scar Treatment Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Scar Type
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Scar Treatment Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Scar Type
      • 10.3.1.2.3. By End User
  • 10.3.2. Saudi Arabia Scar Treatment Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Scar Type
      • 10.3.2.2.3. By End User
  • 10.3.3. UAE Scar Treatment Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Scar Type
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Global Scar Treatment Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Smith & Nephew PLC
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Lumenis Ltd.
• 15.3. Merz Pharmaceuticals, LLC
• 15.4. Sonoma Pharmaceuticals, Inc.
• 15.5. Cynosure, LLC
• 15.6. CCA Industries, Inc.
• 15.7. Newmedical Technology Inc.
• 15.8. Molnlycke Health Care AB
• 15.9. Perrigo Company plc
• 15.10. Enaltus LLC

16. Strategic Recommendations

17. About Us & Disclaimer